Patricia Jiménez-Aguilar

Risk of Liver Decompensation Among HIV/Hepatitis C Virus-Coinfected Individuals With Advanced Fibrosis: Implications for the Timing of Therapy

Manuel Márquez, Francisco Téllez, Dolores Merino et al. · Clinical Infectious Diseases · 2013 · 35 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +17

Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens

Luís F. López‐Cortés, Manuel Castaño, Miguel Ángel López‐Ruz et al. · PLoS ONE · 2016 · 18 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Unsolicited consultation by infectious diseases specialist improves outcomes in patients with bloodstream infection: A prospective cohort study

Patricia Jiménez-Aguilar, Alberto Romero-Palacios, Iría-Jesus De-la-Calle et al. · Journal of Infection · 2018 · 11 citations

Veterinary Medicine, Infectious Diseases, Internal Medicine +12

Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study

Karin Neukam, Núria Espinosa, Antonio Collado et al. · PLoS ONE · 2016 · 10 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy

Antonio Rivero‐Juárez, Luís F. López‐Cortés, Manuel Castaño et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2016 · 10 citations · Full text

Medicine, Health Sciences, Infectious Diseases +17